All PODD Content

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

Insulet Corporation (NASDAQ: PODD) Q1 2025 Earnings Call dated May. 08, 2025 Corporate Participants: June Lazaroff — Senior Director of...

April 1, 202639 min read

Insulet Corporation (PODD) Q1 2025 Earnings Call

Insulet Corporation (NASDAQ: PODD) Q1 2025 Earnings Conference

April 1, 20261 min read

Insulet Corporation (PODD) Q1 2026 Earnings Call

Insulet Corporation (NASDAQ: PODD) Q1 2026 Earnings Conference

April 1, 20261 min read

Insulet Corporation (PODD) Q1 2026 Earnings Announcement

Insulet Corporation (NASDAQ: PODD) Q1 2026 Earnings Announcement

April 1, 20261 min read

Insulet Corporation (PODD) Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet Corporation (NASDAQ: PODD) FY 2026 Management Update

March 30, 20261 min read

Insulet Corporation (PODD) Sec Form 8K

Insulet Corporation (NASDAQ: PODD) Sec Form 8K

March 13, 20261 min read

Insulet Corporation (PODD) Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S.

Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release

March 12, 20261 min read

Insulet Corporation (PODD) Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release

March 11, 20261 min read

Insulet Corporation (PODD) Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release

March 10, 20261 min read

Insulet Corporation (PODD) Sec Form 8K

Insulet Corporation (NASDAQ: PODD) Sec Form 8K

March 6, 20261 min read